Skip to main content
Quest Diagnostics

The Emerging Role of Blood-based Biomarkers in Alzheimer's Disease

On-demand Webinar:

 

The objectives of this webinar include:

 

• A discussion of the current opportunities and challenges in diagnosing Alzheimer's disease

 

• A discourse on the emerging role of blood-based biomarkers (eg, P-tau, A β42/A β40, NfL) in Alzheimer's disease screening and monitoring

 

• An exploration of emerging treatments and new diagnostic pathways for Alzheimer's disease

 

Date:
Mar 29, 2022
Location:
Virtual
Presenter(s):
Dr Stephen Salloway and Dr Michael Racke
Moderator(s):
Gabriele Olla

Stephen P. Salloway, MD, MS

Michael K. Racke, MD

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.